befloxatone has been researched along with methoxyhydroxyphenylglycol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubin, N; Curet, O; Damoiseau, G; Jarreau, FX; Rovei, V; Sontag, N | 1 |
| Allain, H; Cimarosti, I; Curet, O; Dubruc, C; Durrieu, G; Gandon, JM; Jezequel, S; le Coz, F; Patat, A; Rosenzweig, P; Zieleniuk, I | 1 |
| Curet, O; Dubruc, C; Durrieu, G; Legangneux, E; Patat, A; Rosenzweig, P; Zieleniuk, I | 1 |
2 trial(s) available for befloxatone and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteers.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Humans; Male; Metabolic Clearance Rate; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles | 1996 |
Clinical pharmacology of befloxatone: a brief review.
Topics: Adult; Aged; Brain; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Oxazoles; Placebos; Psychomotor Performance; Tyramine | 1998 |
1 other study(ies) available for befloxatone and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile.
Topics: Animals; Biogenic Monoamines; Brain; Duodenum; Humans; Liver; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Rats; Rats, Sprague-Dawley | 1996 |